Anemia, Endoscopy, Iron Deficiency Anemia
Conditions
Keywords
Sudan, Gastrointestinal blood loss, Endoscopic findings
Brief summary
Background: Iron deficiency anemia (IDA) is a common condition often linked to gastrointestinal blood loss, making endoscopic evaluation essential for identifying underlying causes. This study aimed to assess the endoscopic findings in patients presenting with IDA in Red Sea State, Sudan. Understanding the prevalence and types of gastrointestinal lesions among these patients can aid in early diagnosis and management, reducing associated morbidity and mortality. By focusing on patients undergoing endoscopic evaluation, this study provides valuable insights into the burden of gastrointestinal pathologies contributing to IDA in the region. Materials and Methods: This cross-sectional, descriptive study was conducted in the Endoscopy Unit at Alkaleej Medical Complex - Portsudan. Adults aged ≥18 years with IDA undergoing endoscopic evaluation were included, excluding those unwilling participation or with incomplete data. Data were collected via structured questionnaires and medical records, covering demographics, medical history, clinical presentation, and endoscopic findings. SPSS version 26 - 2018, was used for analysis, applying descriptive statistics and chi-square tests to assess associations. Ethical approval was obtained, and informed consent was secured from all participants.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults aged 18 years and above. * Patients diagnosed with IDA who underwent endoscopic evaluation.
Exclusion criteria
* Patients who declined to participate in the study. * Patients with incomplete medical records or missing endoscopic findings.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of patients with endoscopic lesions explaining iron deficiency anemia | 4 months | Percentage of participants with one or more endoscopic findings potentially accounting for IDA (e.g., gastric/duodenal ulcer, gastritis with bleeding, colonic mass/ulcer, angiodysplasia), confirmed by endoscopy ± biopsy when indicated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of biopsy-proven malignancies | 4 months | Percentage of participants with histopathology-confirmed gastrointestinal malignancy (e.g., gastric adenocarcinoma, colorectal cancer). |
Countries
Sudan